Lieberman, J A
Girgis, R R
Brucato, G
Moore, H
Provenzano, F
Kegeles, L
Javitt, D
Kantrowitz, J
Wall, M M
Corcoran, C M
Schobel, S A
Small, S A
Article History
Received: 29 June 2017
Revised: 18 September 2017
Accepted: 27 September 2017
First Online: 9 January 2018
Conflict of Interest
: Dr. Lieberman (JAL) has received support administered through his institution in the form of funding or medication supplies for investigator initiated research from Denovo, Taisho, Pfizer, Sunovion and Genentech, and for company sponsored phase II, III and IV studies from Alkermes and Allergan, and is a consultant to or member of the advisory board of Intracellular Therapies, Lilly, Pierre Fabre and Psychogenics. He neither accepts nor receives any personal financial remuneration for consulting, speaking or research activities from any pharmaceutical, biotechnology or medical device companies. He has received honoraria for serving on an advisory board for Clintara, a clinical research organization, and holds a patent from Repligen that yields no royalties. Dr. Lieberman has received support administered through his institution in the form of funding or medication supplies for investigator initiated research from Denovo, Taisho, Pfizer, Sunovion and Genentech, and for company sponsored phase II, III and IV studies from Alkermes and Allergan, and is a consultant to or member of the advisory board of Intracellular Therapies, Lilly, Pierre Fabre and Psychogenics. He neither accepts nor receives any personal financial remuneration for consulting, speaking or research activities from any pharmaceutical, biotechnology or medical device companies. He has received honoraria for serving on an advisory board for Clintara, a clinical research organization, and holds a patent from Repligen that yields no royalties. Dr. Girgis (RRG) has received research support from Otsuka, Genentech, Allergan and Bioadvantex. Dr. Small (SAS) is a member of the advisory board for Janssen Pharmaceutical, Denali Therapeutics and Meira GTx. Drs. Brucato (GB), Javitt (DJ), Kegeles (LK), Kantrowitz (JK), Corcoran (CMC), Moore (HM), Provenzano (FP), Schobel (SAS) and Wall (MMW) declare no conflict of interest.